The Antibody Engineering & Therapeutics Europe conference serves as the intersection of pioneering science and collaborative engagement. For over 25 years, this premier forum dedicated to antibody engineering, therapeutics, and immunobiology has convened leading academic and industry scientists to expedite research, discovery, and clinical progress.
This year marks an exciting occasion as the event welcomes attendees to Basel, Switzerland—a dynamic biotech center and an ideal location for transformative discussions, networking, and innovation.
With the expert guidance of The Antibody Society—whose members contribute as Scientific Advisors and Session Chairs—the conference offers exceptional avenues for knowledge sharing and collaboration.
Attendees are invited to explore groundbreaking topics, including Fc Engineering, Novel Approaches to Antibody Discovery, Multispecific Antibodies, Agonists, Conditionally Active Biotherapeutics, ADCs, Degraders, Theranostics, and a wide range of other cutting-edge areas.
